Zubsolv® (buprenorphine and naloxone) sublingual tablet (CIII) is indicated for the maintenance treatment of opioid dependence and should be used as part of a comprehensive treatment plan, which includes counseling and psychosocial support.
Abstral is a drug that provides fast and effective treatment of breakthrough pain in cancer patients. It is based on Orexo's sublingual tablet technology and the analgesic fentanyl.
Edluar is based on Orexo’s sublingual tablet technology and the active substance zolpidem and offers treatment for short-term insomnia. Zolpidem is a well-documented substance that has been used for a long time against insomnia. The Edluar tablet is placed under the tongue where it rapidly dissolves and the active substance is absorbed through the mucous membrane.
Diabact UBT is used to diagnose the presence of Helicobacter pylori, the bacterium that causes gastric ulcers. The product is a breath test based on Orexo’s patented tablet technology for rapidly dissolving tablets. The breath test takes ten minutes to carry out and is then sent to a laboratory for analysis.
Heliprobe System is a “doctor’s office test” for the presence of the gastric ulcer bacterium, Helicobacter pylori. The product has a number of advantages including high reliability, painless administration, a short test time and on-site results.